Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan.
Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, MA.
Am J Kidney Dis. 2014 Jan;63(1):49-58. doi: 10.1053/j.ajkd.2013.07.023. Epub 2013 Sep 26.
South Asians are at high risk for chronic kidney disease. However, unlike those in the United States and United Kingdom, laboratories in South Asian countries do not routinely report estimated glomerular filtration rate (eGFR) when serum creatinine is measured. The objectives of the study were to: (1) evaluate the performance of existing GFR estimating equations in South Asians, and (2) modify the existing equations or develop a new equation for use in this population.
Cross-sectional population-based study.
SETTING & PARTICIPANTS: 581 participants 40 years or older were enrolled from 10 randomly selected communities and renal clinics in Karachi.
eGFR, age, sex, serum creatinine level.
Bias (the median difference between measured GFR [mGFR] and eGFR), precision (the IQR of the difference), accuracy (P30; percentage of participants with eGFR within 30% of mGFR), and the root mean squared error reported as cross-validated estimates along with bootstrapped 95% CIs based on 1,000 replications.
The CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) creatinine equation performed better than the MDRD (Modification of Diet in Renal Disease) Study equation in terms of greater accuracy at P30 (76.1% [95% CI, 72.7%-79.5%] vs 68.0% [95% CI, 64.3%-71.7%]; P < 0.001) and improved precision (IQR, 22.6 [95% CI, 19.9-25.3] vs 28.6 [95% CI, 25.8-31.5] mL/min/1.73 m(2); P < 0.001). However, both equations overestimated mGFR. Applying modification factors for slope and intercept to the CKD-EPI equation to create a CKD-EPI Pakistan equation (such that eGFRCKD-EPI(PK) = 0.686 × eGFRCKD-EPI(1.059)) in order to eliminate bias improved accuracy (P30, 81.6% [95% CI, 78.4%-84.8%]; P < 0.001) comparably to new estimating equations developed using creatinine level and additional variables.
Lack of external validation data set and few participants with low GFR.
The CKD-EPI creatinine equation is more accurate and precise than the MDRD Study equation in estimating GFR in a South Asian population in Karachi. The CKD-EPI Pakistan equation further improves the performance of the CKD-EPI equation in South Asians and could be used for eGFR reporting.
南亚人患慢性肾脏病的风险很高。然而,与美国和英国不同的是,南亚国家的实验室在测量血清肌酐时通常不会报告估算肾小球滤过率(eGFR)。本研究的目的是:(1)评估现有 GFR 估算方程在南亚人群中的表现,(2)修改现有的方程或为该人群开发新的方程。
横断面基于人群的研究。
从 10 个随机选择的社区和卡拉奇的肾脏诊所招募了 581 名年龄在 40 岁或以上的参与者。
eGFR、年龄、性别、血清肌酐水平。
偏倚(实测 GFR [mGFR]和 eGFR 之间的中位数差异)、精密度(差异的 IQR)、准确性(P30;eGFR 在 mGFR 的 30%范围内的参与者百分比)和均方根误差以交叉验证估计值报告,并基于 1000 次重复的 bootstrap 95%CI。
在 P30 时,CKD-EPI(慢性肾脏病流行病学合作)肌酐方程的准确性优于 MDRD(肾脏病饮食改良研究)方程(76.1%[95%CI,72.7%-79.5%]与 68.0%[95%CI,64.3%-71.7%];P<0.001),且精密度提高(IQR,22.6[95%CI,19.9-25.3]与 28.6[95%CI,25.8-31.5]mL/min/1.73 m(2);P<0.001)。然而,两个方程都高估了 mGFR。为了消除偏倚,对 CKD-EPI 方程应用斜率和截距修正因子,创建 CKD-EPI 巴基斯坦方程(使得 eGFRCKD-EPI(PK)=0.686×eGFRCKD-EPI(1.059)),以提高准确性(P30,81.6%[95%CI,78.4%-84.8%];P<0.001),与使用肌酐水平和其他变量开发的新估算方程相当。
缺乏外部验证数据集和低 GFR 参与者较少。
在卡拉奇的南亚人群中,CKD-EPI 肌酐方程在估计 GFR 方面比 MDRD 研究方程更准确和精确。CKD-EPI 巴基斯坦方程进一步提高了 CKD-EPI 方程在南亚人群中的表现,可用于 eGFR 报告。